Cargando…
A bisphosphonate for (19)F-magnetic resonance imaging
(19)F-magnetic resonance imaging (MRI) is a promising technique that may allow us to measure the concentration of exogenous fluorinated imaging probes quantitatively in vivo. Here, we describe the synthesis and characterisation of a novel geminal bisphosphonate ((19)F-BP) that contains chemically-eq...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Sequoia Sa
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834630/ https://www.ncbi.nlm.nih.gov/pubmed/27110036 http://dx.doi.org/10.1016/j.jfluchem.2016.02.008 |
_version_ | 1782427519240110080 |
---|---|
author | Kenny, Gavin D. Shaw, Karen P. Sivachelvam, Saranja White, Andrew J.P. Botnar, Rene M. T.M. de Rosales, Rafael |
author_facet | Kenny, Gavin D. Shaw, Karen P. Sivachelvam, Saranja White, Andrew J.P. Botnar, Rene M. T.M. de Rosales, Rafael |
author_sort | Kenny, Gavin D. |
collection | PubMed |
description | (19)F-magnetic resonance imaging (MRI) is a promising technique that may allow us to measure the concentration of exogenous fluorinated imaging probes quantitatively in vivo. Here, we describe the synthesis and characterisation of a novel geminal bisphosphonate ((19)F-BP) that contains chemically-equivalent fluorine atoms that show a single and narrow (19)F resonance and a bisphosphonate group that may be used for labelling inorganic materials based in calcium phosphates and metal oxides. The potential of (19)F-BP to provide contrast was analysed in vitro and in vivo using (19)F-MRI. In vitro studies demonstrated the potential of (19)F-BP as an MRI contrast agent in the millimolar concentration range with signal-to-noise ratios (SNR) comparable to previously reported fluorinated probes. The preliminary in vivo MRI study reported here allowed us to visualise the biodistribution of (19)F-BP, showing uptake in the liver and in the bladder/urinary system areas. However, bone uptake was not observed. In addition, (19)F-BP showed undesirable toxicity effects in mice that prevent further studies with this compound at the required concentrations for MRI contrast. This study highlights the importance of developing (19)F MRI probes with the highest signal intensity achievable. |
format | Online Article Text |
id | pubmed-4834630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier Sequoia Sa |
record_format | MEDLINE/PubMed |
spelling | pubmed-48346302016-04-20 A bisphosphonate for (19)F-magnetic resonance imaging Kenny, Gavin D. Shaw, Karen P. Sivachelvam, Saranja White, Andrew J.P. Botnar, Rene M. T.M. de Rosales, Rafael J Fluor Chem Article (19)F-magnetic resonance imaging (MRI) is a promising technique that may allow us to measure the concentration of exogenous fluorinated imaging probes quantitatively in vivo. Here, we describe the synthesis and characterisation of a novel geminal bisphosphonate ((19)F-BP) that contains chemically-equivalent fluorine atoms that show a single and narrow (19)F resonance and a bisphosphonate group that may be used for labelling inorganic materials based in calcium phosphates and metal oxides. The potential of (19)F-BP to provide contrast was analysed in vitro and in vivo using (19)F-MRI. In vitro studies demonstrated the potential of (19)F-BP as an MRI contrast agent in the millimolar concentration range with signal-to-noise ratios (SNR) comparable to previously reported fluorinated probes. The preliminary in vivo MRI study reported here allowed us to visualise the biodistribution of (19)F-BP, showing uptake in the liver and in the bladder/urinary system areas. However, bone uptake was not observed. In addition, (19)F-BP showed undesirable toxicity effects in mice that prevent further studies with this compound at the required concentrations for MRI contrast. This study highlights the importance of developing (19)F MRI probes with the highest signal intensity achievable. Elsevier Sequoia Sa 2016-04 /pmc/articles/PMC4834630/ /pubmed/27110036 http://dx.doi.org/10.1016/j.jfluchem.2016.02.008 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kenny, Gavin D. Shaw, Karen P. Sivachelvam, Saranja White, Andrew J.P. Botnar, Rene M. T.M. de Rosales, Rafael A bisphosphonate for (19)F-magnetic resonance imaging |
title | A bisphosphonate for (19)F-magnetic resonance imaging |
title_full | A bisphosphonate for (19)F-magnetic resonance imaging |
title_fullStr | A bisphosphonate for (19)F-magnetic resonance imaging |
title_full_unstemmed | A bisphosphonate for (19)F-magnetic resonance imaging |
title_short | A bisphosphonate for (19)F-magnetic resonance imaging |
title_sort | bisphosphonate for (19)f-magnetic resonance imaging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834630/ https://www.ncbi.nlm.nih.gov/pubmed/27110036 http://dx.doi.org/10.1016/j.jfluchem.2016.02.008 |
work_keys_str_mv | AT kennygavind abisphosphonatefor19fmagneticresonanceimaging AT shawkarenp abisphosphonatefor19fmagneticresonanceimaging AT sivachelvamsaranja abisphosphonatefor19fmagneticresonanceimaging AT whiteandrewjp abisphosphonatefor19fmagneticresonanceimaging AT botnarrenem abisphosphonatefor19fmagneticresonanceimaging AT tmderosalesrafael abisphosphonatefor19fmagneticresonanceimaging AT kennygavind bisphosphonatefor19fmagneticresonanceimaging AT shawkarenp bisphosphonatefor19fmagneticresonanceimaging AT sivachelvamsaranja bisphosphonatefor19fmagneticresonanceimaging AT whiteandrewjp bisphosphonatefor19fmagneticresonanceimaging AT botnarrenem bisphosphonatefor19fmagneticresonanceimaging AT tmderosalesrafael bisphosphonatefor19fmagneticresonanceimaging |